Secondly, although we found that dexmedetomidine evidently protected the liver against ALI, the advantage of this treatment was not evidenced with a variety of proinflammatory cytokines such as macrophage inflammatory protein (MIP)-1, tumor necrosis factor (TNF)-α, or interleukin (IL)-1β. This evidence concerns the gene TNF and acute respiratory distress syndrome.